{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:07:18Z","timestamp":1789376838964,"version":"build-2803163510"},"reference-count":64,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Obstructive sleep apnea (OSA) and metabolic dysfunction-associated steatotic liver disease (MASLD) frequently coexist in children with obesity, but data on hepatic outcomes following OSA treatment are limited. This study evaluated associations between targeted OSA treatment and longitudinal changes in sleep-disordered breathing and hepatic outcomes. Methods: This retrospective observational cohort included children aged 4\u201318 years with obesity, polysomnography-confirmed OSA, and ultrasonography-confirmed MASLD who received clinical care between 2018 and 2025. Children received targeted OSA treatment (adenotonsillectomy and\/or continuous positive airway pressure [CPAP]) or non-targeted treatment. Polysomnographic parameters, liver enzymes, and ultrasonographic hepatic steatosis were assessed at baseline and 6\u201312 months. The primary outcome was a \u226530% reduction in alanine aminotransferase (ALT). Results: Among 127 children, 67 received targeted treatment and 60 did not. Targeted treatment was associated with improvements in OSA severity, nocturnal oxygenation, ALT, AST, and ultrasonographic steatosis, whereas less favorable trajectories occurred without targeted treatment. ALT reduction differed significantly among treatment modalities, with the greatest reduction observed with CPAP. In multivariable analyses, CPAP was associated with both \u226530% ALT reduction (OR 14.54, 95% CI 3.87\u201354.69; p &lt; 0.01) and ultrasonographic improvement (OR 3.33, 95% CI 1.16\u20139.59; p = 0.03). A BMI z-score reduction of \u22650.25 was not independently associated with either hepatic outcome. Conclusions: Targeted OSA treatment was associated with more favorable sleep and hepatic outcomes, with the strongest associations observed for CPAP. Prospective studies are needed to determine whether these associations represent causal treatment effects.<\/jats:p>","DOI":"10.3390\/children13091241","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:10:23Z","timestamp":1789373423000},"page":"1241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcome of Targeted Therapy for Obstructive Sleep Apnea in Children with Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)"],"prefix":"10.3390","volume":"13","author":[{"given":"Woranart","family":"Ratanakorn","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Chonburi Hospital, Chonburi 20000, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_2","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2024). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol., 81, 492\u2013542."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease","volume":"19","author":"Eslam","year":"2025","journal-title":"Hepatol. Int."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Association for the Study of the Liver (EASL), North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), Latin-American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (LASPGHAN), Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition (APPSPGHAN), Pan Arab Society for Pediatric Gastroenterology and Nutrition (PASPGHAN), Commonwealth Association of Paediatric Gastroenterology & Nutrition (CAPGAN), and Federation of International Societies of Pediatric Hepatology, Gastroenterology and Nutrition (FISPGHAN) (2024). Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature. J. Pediatr. Gastroenterol. Nutr., 78, 1190\u20131196.","DOI":"10.1002\/jpn3.12156"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Anderson, E.L., Howe, L.D., Jones, H.E., Higgins, J.P.T., A Lawlor, D., and Fraser, A. (2015). The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140908"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/j.gastro.2016.03.009","article-title":"Comparison of the Phenotype and Approach to Pediatric vs. Adult Patients with Nonalcoholic Fatty Liver Disease","volume":"150","author":"Nobili","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: A follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1111\/j.1572-0241.2002.06003.x","article-title":"Obese children with steatohepatitis can develop cirrhosis in childhood","volume":"97","author":"Molleston","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cld.2015.10.003","article-title":"The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease","volume":"20","author":"Goyal","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1357\u20131364, 1364.e1\u20131364.e2","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: Alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.201806-1109TR","article-title":"Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease","volume":"199","author":"Mesarwi","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jhep.2011.04.022","article-title":"Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese","volume":"56","author":"Minville","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3748\/wjg.v26.i20.2669","article-title":"Association between non-alcoholic fatty liver disease and obstructive sleep apnea","volume":"26","author":"Umbro","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tang, H., Lv, F., Zhang, P., Liu, J., and Mao, J. (2023). The impact of obstructive sleep apnea on nonalcoholic fatty liver disease. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1254459"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2147\/NSS.S468420","article-title":"Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment","volume":"16","author":"Wang","year":"2024","journal-title":"Nat. Sci. Sleep"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1542\/peds.2012-1672","article-title":"Diagnosis and management of childhood obstructive sleep apnea syndrome","volume":"130","author":"Marcus","year":"2012","journal-title":"Pediatrics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1183\/13993003.00385-2015","article-title":"Obstructive sleep disordered breathing in 2- to 18-year-old children: Diagnosis and management","volume":"47","author":"Kaditis","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_27","unstructured":"American Academy of Sleep Medicine (2023). The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, American Academy of Sleep Medicine. [3rd ed.]."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccm.2010.02.002","article-title":"Pediatric obstructive sleep apnea syndrome","volume":"31","author":"Katz","year":"2010","journal-title":"Clin. Chest Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.prrv.2006.08.003","article-title":"Obesity and obstructive sleep apnea in children","volume":"7","author":"Tauman","year":"2006","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.5665\/sleep.3666","article-title":"Obstructive sleep apnea in obese community-dwelling children: The NANOS study","volume":"37","author":"Gozal","year":"2014","journal-title":"Sleep"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1378\/chest.08-0535","article-title":"Sleep-disordered breathing, obesity, and airway inflammation in children and adolescents","volume":"134","author":"Verhulst","year":"2008","journal-title":"Chest"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1749-6632.2012.06723.x","article-title":"Childhood obesity and sleep: Relatives, partners, or both?\u2014A critical perspective on the evidence","volume":"1264","author":"Gozal","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1164\/rccm.200804-608OC","article-title":"Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity","volume":"179","author":"Polotsky","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"G871","DOI":"10.1152\/ajpgi.00145.2007","article-title":"Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver","volume":"293","author":"Savransky","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1152\/japplphysiol.00522.2005","article-title":"Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice","volume":"99","author":"Li","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4187\/respcare.01184","article-title":"Influence of obstructive sleep apnea on fatty liver disease: Role of chronic intermittent hypoxia","volume":"57","author":"Turkay","year":"2012","journal-title":"Respir. Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1378\/chest.13-0938","article-title":"Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea","volume":"145","author":"Minville","year":"2014","journal-title":"Chest"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.cgh.2016.04.037","article-title":"Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury","volume":"14","author":"Trzepizur","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.5664\/jcsm.7262","article-title":"Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea","volume":"14","author":"Kim","year":"2018","journal-title":"J. Clin. Sleep Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5664\/jcsm.6900","article-title":"Continuous Positive Airway Pressure in Patients with Obstructive Sleep Apnea and Non-Alcoholic Steatohepatitis: A Systematic Review and Meta-Analysis","volume":"14","author":"Labarca","year":"2018","journal-title":"J. Clin. Sleep Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/crj.12554","article-title":"Effect of continuous positive airway pressure on liver enzymes in obstructive sleep apnea: A meta-analysis","volume":"12","author":"Chen","year":"2018","journal-title":"Clin. Respir. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.12998\/wjcc.v9.i19.5112","article-title":"Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea","volume":"9","author":"Hirono","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1164\/rccm.202005-1868OC","article-title":"Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial","volume":"203","author":"Ng","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jpeds.2013.10.072","article-title":"Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease","volume":"164","author":"Sundaram","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2016.04.010","article-title":"Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease","volume":"65","author":"Sundaram","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1164\/rccm.201307-1339OC","article-title":"Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity\/insulin resistance","volume":"189","author":"Nobili","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e12718","DOI":"10.1111\/ijpo.12718","article-title":"Association between obstructive sleep apnea and non-alcoholic fatty liver disease in pediatric patients: A meta-analysis","volume":"16","author":"Chen","year":"2021","journal-title":"Pediatr. Obes."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Carotenuto, M., Di Sessa, A., Esposito, M., Grandone, A., Marzuillo, P., Bitetti, I., Umano, G.R., Precenzano, F., del Giudice, E.M., and Santoro, N. (2021). Association between Hepatic Steatosis and Obstructive Sleep Apnea in Children and Adolescents with Obesity. Children, 8.","DOI":"10.3390\/children8110984"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1164\/rccm.200912-1930OC","article-title":"Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: A multicenter retrospective study","volume":"182","author":"Bhattacharjee","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1215881","article-title":"A randomized trial of adenotonsillectomy for childhood sleep apnea","volume":"368","author":"Marcus","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.otohns.2007.03.028","article-title":"Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children","volume":"137","author":"Mitchell","year":"2007","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jpeds.2006.08.067","article-title":"Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy","volume":"149","author":"Tauman","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1542\/peds.2005-1634","article-title":"Adherence to and effectiveness of positive airway pressure therapy in children with obstructive sleep apnea","volume":"117","author":"Marcus","year":"2006","journal-title":"Pediatrics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/ajrccm.152.2.7633742","article-title":"Obstructive sleep apnea: The use of nasal CPAP in 80 children","volume":"152","author":"Waters","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpeds.2018.03.028","article-title":"Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children","volume":"198","author":"Sundaram","year":"2018","journal-title":"J. Pediatr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/hep.22336","article-title":"Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.31317","article-title":"Alanine Aminotransferase and Gamma-Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis","volume":"73","author":"Newton","year":"2021","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/HEP.0000000000001216","article-title":"Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes","volume":"82","author":"Newton","year":"2025","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpeds.2022.07.004","article-title":"Clinically Meaningful Body Mass Index Change Impacts Pediatric Nonalcoholic Fatty Liver Disease","volume":"250","author":"Khurana","year":"2022","journal-title":"J. Pediatr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11325-026-03714-y","article-title":"The triadic relationship between obesity, obstructive sleep apnea and metabolic dysfunction-associated steatotic liver disease in children: A scoping review","volume":"30","author":"Beeldens","year":"2026","journal-title":"Sleep Breath"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ilar.50.3.289","article-title":"Metabolic consequences of sleep-disordered breathing","volume":"50","author":"Jun","year":"2009","journal-title":"ILAR J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"230166","DOI":"10.1183\/16000617.0166-2023","article-title":"REM sleep obstructive sleep apnoea","volume":"33","author":"Bonsignore","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Karuga, F.F., Kaczmarski, P., Bia\u0142asiewicz, P., Szmyd, B., Jaromirska, J., Grzybowski, F., Gebuza, P., Sochal, M., and Gabryelska, A. (2023). REM-OSA as a Tool to Understand Both the Architecture of Sleep and Pathogenesis of Sleep Apnea-Literature Review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185907"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/9\/1241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:57:23Z","timestamp":1789376243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/9\/1241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":64,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["children13091241"],"URL":"https:\/\/doi.org\/10.3390\/children13091241","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}